A Ten-N(6)-Methyladenosine (m(6)A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma

OBJECTIVES: The study aims to analyze the expression of N(6)-methyladenosine (m(6)A)-modified genes in rectum adenocarcinoma (READ) and identify reliable prognostic biomarkers to predict the prognosis of READ. MATERIALS AND METHODS: RNA sequence data of READ and corresponding clinical survival data...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wei, Li, Gen, Wang, Zihang, Zhou, Lin, Yin, Xin, Yang, Tianshu, Wang, Pei, Teng, Xu, Feng, Yajuan, Yu, Hefen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925823/
https://www.ncbi.nlm.nih.gov/pubmed/33680913
http://dx.doi.org/10.3389/fonc.2020.567931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925823/
https://www.ncbi.nlm.nih.gov/pubmed/33680913
http://dx.doi.org/10.3389/fonc.2020.567931

Ejemplares similares